Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
Saved in:
| Title: | Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. |
|---|---|
| Authors: | Trabelsi MS; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Daoudi M; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Prawitt J; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Ducastel S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Touche V; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Sayin SI; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden., Perino A; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland., Brighton CA; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Sebti Y; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Kluza J; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France., Briand O; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Dehondt H; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Vallez E; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Dorchies E; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Baud G; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Spinelli V; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Hennuyer N; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Caron S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Bantubungi K; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Caiazzo R; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Reimann F; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Marchetti P; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France., Lefebvre P; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Bäckhed F; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.; Section for Metabolic Receptology and Enteroendocrinology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen 2200, Denmark., Gribble FM; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Schoonjans K; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland., Pattou F; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Tailleux A; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Staels B; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Lestavel S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France. |
| Source: | Nature communications [Nat Commun] 2015 Jul 02; Vol. 6, pp. 7629. Date of Electronic Publication: 2015 Jul 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26134028 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Trabelsi+MS%22">Trabelsi MS</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Daoudi+M%22">Daoudi M</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Prawitt+J%22">Prawitt J</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Ducastel+S%22">Ducastel S</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Touche+V%22">Touche V</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Sayin+SI%22">Sayin SI</searchLink>; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.<br /><searchLink fieldCode="AU" term="%22Perino+A%22">Perino A</searchLink>; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.<br /><searchLink fieldCode="AU" term="%22Brighton+CA%22">Brighton CA</searchLink>; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.<br /><searchLink fieldCode="AU" term="%22Sebti+Y%22">Sebti Y</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Kluza+J%22">Kluza J</searchLink>; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France.<br /><searchLink fieldCode="AU" term="%22Briand+O%22">Briand O</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Dehondt+H%22">Dehondt H</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Vallez+E%22">Vallez E</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Dorchies+E%22">Dorchies E</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Baud+G%22">Baud G</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Spinelli+V%22">Spinelli V</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Hennuyer+N%22">Hennuyer N</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Caron+S%22">Caron S</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Bantubungi+K%22">Bantubungi K</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Caiazzo+R%22">Caiazzo R</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Reimann+F%22">Reimann F</searchLink>; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.<br /><searchLink fieldCode="AU" term="%22Marchetti+P%22">Marchetti P</searchLink>; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France.<br /><searchLink fieldCode="AU" term="%22Lefebvre+P%22">Lefebvre P</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Bäckhed+F%22">Bäckhed F</searchLink>; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.; Section for Metabolic Receptology and Enteroendocrinology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen 2200, Denmark.<br /><searchLink fieldCode="AU" term="%22Gribble+FM%22">Gribble FM</searchLink>; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.<br /><searchLink fieldCode="AU" term="%22Schoonjans+K%22">Schoonjans K</searchLink>; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pattou+F%22">Pattou F</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Tailleux+A%22">Tailleux A</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Staels+B%22">Staels B</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Lestavel+S%22">Lestavel S</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2015 Jul 02; Vol. 6, pp. 7629. <i>Date of Electronic Publication: </i>2015 Jul 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26134028 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/ncomms8629 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 7629 Titles: – TitleFull: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Trabelsi MS – PersonEntity: Name: NameFull: Daoudi M – PersonEntity: Name: NameFull: Prawitt J – PersonEntity: Name: NameFull: Ducastel S – PersonEntity: Name: NameFull: Touche V – PersonEntity: Name: NameFull: Sayin SI – PersonEntity: Name: NameFull: Perino A – PersonEntity: Name: NameFull: Brighton CA – PersonEntity: Name: NameFull: Sebti Y – PersonEntity: Name: NameFull: Kluza J – PersonEntity: Name: NameFull: Briand O – PersonEntity: Name: NameFull: Dehondt H – PersonEntity: Name: NameFull: Vallez E – PersonEntity: Name: NameFull: Dorchies E – PersonEntity: Name: NameFull: Baud G – PersonEntity: Name: NameFull: Spinelli V – PersonEntity: Name: NameFull: Hennuyer N – PersonEntity: Name: NameFull: Caron S – PersonEntity: Name: NameFull: Bantubungi K – PersonEntity: Name: NameFull: Caiazzo R – PersonEntity: Name: NameFull: Reimann F – PersonEntity: Name: NameFull: Marchetti P – PersonEntity: Name: NameFull: Lefebvre P – PersonEntity: Name: NameFull: Bäckhed F – PersonEntity: Name: NameFull: Gribble FM – PersonEntity: Name: NameFull: Schoonjans K – PersonEntity: Name: NameFull: Pattou F – PersonEntity: Name: NameFull: Tailleux A – PersonEntity: Name: NameFull: Staels B – PersonEntity: Name: NameFull: Lestavel S IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 07 Text: 2015 Jul 02 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 6 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |